Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506)

Vaccine

Volumn 15, Issue 15, 1997, Pages 1598-1605

  Ogawa, Tomohiko ^a   Suda, Yasuo ^a   Kashihara, Wataru ^b   Hayashi, Tomoko ^b   Shimoyama, Takashi ^b   Kusumoto, Shoichi ^a   Tamura, Toshihide ^b  

^a OSAKA UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Helicobacter pylori lipid A; Immunobiological activity; Porphyromonas gingivalis

Indexed keywords

ENDOTOXIN; GLUCOSAMINE; INTERLEUKIN 6; LIPID A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CONTROLLED STUDY; HELICOBACTER PYLORI; IMMUNOBIOLOGY; IMMUNOREACTIVITY; LIMULUS LYSATE TEST; MITOGENESIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PORPHYROMONAS; PRIORITY JOURNAL;

ANIMALS; CYTOKINES; ESCHERICHIA COLI; HELICOBACTER PYLORI; HEMAGGLUTINATION; HUMANS; KILLER CELLS, NATURAL; LIPID A; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; PORPHYROMONAS GINGIVALIS; RABBITS;

EID: 0030861974     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00102-3     Document Type: Article

References (46)

1. Warren, J.R. and Marshall, B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983, 1, 1273-1275.
2. Buck, G.E., Gourley, W.K., Lee, W.K., Subramanyan, K., Latimer, J.M. and DiNuzzo, A.R. Relation of Campylobacter pyloridis to gastritis and peptic ulcer. Journal of Infectious Diseases 1986, 153, 664-669.
3. O'Connor, H.J. The role of Helicobacter pylori in peptic ulcer disease. Scandinavian Journal of Gastroenterology 1994, 201, 11-15.
4. Goodwin, C.S. The impact of microbiological discoveries such as Helicobacter pylori on gastroenterology, and the implications for microbiologists. Medical Microbiology Letters 1995, 4, 155-164.
5. Geis, G., Leying, H., Suerbaum, S. and Opferkuch, W. Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori. Journal of Clinical Microbiology 1990, 28, 930-932.
6. Conrad, R.S., Kist, M., Schlecht, S. and Galanos, C. Extraction and biochemical analyses of Helicobacter pylori lipopolysaccharides. Current Microbiology 1992, 24, 165-169.
7. Moran, A., Helander, I.M. and Kosunen, T.U. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. Journal of Bacteriology 1992, 174, 1370-1377.
8. Muotiala, A., Helander, I.M., Pyhälä, L., Kosunen, T.U. and Moran, A.P. Low biological activity of Helicobacter pylori lipopolysaccharide. Infection and Immunity 1992, 60, 1714-1716.
9. Birkholz, S., Knipp, U., Nietzki, C., Adamek, R.J. and Opferkuch, W. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunology and Medical Microbiology 1993, 6, 317-324.
10. Takayama, K. and Qureshi, N. Chemical structure of lipid A. In: Bacterial Endotoxic Lipopolysacchrides (Eds Morrison, D. C. and Ryan, J. L.). CRC Press, New York, 1992, Vol. 1, pp. 43-65
11. Zähringer, U., Lindner, B. and Rietschel, E.Th. Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. Advances in Carbohydrate Chemistry and Biochemistry 1994, 50, 211-276.
12. Takada, H. and Kotani, S. Structure-function relationships of lipid A. In: Bacterial Endotoxic Lipopolysaccharides (Eds Morrison, D. C. and Ryan, J. L.). CRC Press, New York, 1992, pp. 107-134
13. Rietschel, ET., Brade, H., Brade, L., Brandenburg, K., Schade, U., Seydel, U., Zähringer, U., Galanos, C., Lüderitz, O., Westphal, O., Labischinski, H., Kusumoto, S. and Shiba, T. Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Progress in Clinical and Biological Research 1987, 231, 25-53.
14. Homma, J.Y., Matsuura, M. and Kumazawa, Y. Studies on lipid A, the active center of endotoxin-structure-activity relationship. Drugs Future 1989, 4, 645-665.
15. Suda, Y., Ogawa, T., Kashihara, W., Oikawa, M., Shimoyama, T., Hayashi, T., Tamura, T. and Kusumoto, S. Chemical structure of lipid A from Helicobacter pylori strain 206-1 lipopolysaccharide. Journal of Biochemistry 1997, 121, 1129-1133.
16. Fukuda, Y., Tamura, K., Yamamoto, I., Kawaura, A., Tonokatsu, Y., Tsuyuguchi, T., Ohno, T., Satomi, M. and Shimoyama, T. Inoculation of rhesus monkeys with Helicobacter pylori: A long-term investigation on gastric mucosa by endoscopy. Digestive Endoscopy 1992, 4, 19-30.
17. Westphal, O. and Jann, K. Extraction with phenol and further applications of the procedure. Methods in Carbohydrate Chemistry 1965, 5, 83-91.
18. Ogawa, T. Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide. FEBS Letters 1993, 332, 197-201.
19. Imoto, M., Yoshimura, H., Sakaguchi, N., Kusumoto, S. and Shiba, T. Chemical structure of Escherichia coli lipid A. Tetrahedron Letters 1985, 26, 1545-1548.
20. Galanos, C., Freudenberg, M.A. and Reutter, W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proceedings of the National Academy of Sciences of the United States of America 1979, 76, 5939-5943.
21. Kärber, G. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Archives of Experimental Pathology and Pharmacology 1931, 162, 480-483.
22. Ogawa, T. Immunobiological properties of chemically defined lipid A from lipopolysaccharide of Porphyromonas (Bacteroides) ginigvalis. European Journal of Biochemistry 1994, 219, 737-742.
23. Ogawa, T., Nakazawa, M. and Masui, K. Immunopharmacological activities of the nontoxic monophosphoryl lipid A of Porphyromonas gingivalis. Vaccine 1996, 14, 70-76.
24. Böyum, A. Isolation of mononuclear cells and granulocytes from human blood. Scandinavian Journal of Clinical and Laboratory Investigation 1968, 21, (Suppl. 97), 77-89.
25. Ogawa, T., Ogo, H. and Kinoshita, A. Antagonistic effect of synthetic peptides corresponding to the binding regions within fimbrial subunit protein from Porphyromonas gingivalis to human gingival fibroblasts. Vaccine 1997, 15, 230-236.
26. Andersson, L.C., Nilsson, K. and Gahmberg, C.G. K562 - a human erythroleukemic cell line. International Journal of Cancer 1979, 23, 143-147.
27. Ogawa, T., Uchida, H. and Amino, K. Immunobiological activities of chemically defined lipid A from lipopolysaccharides of Porphyromonas gingivalis. Microbiology 1994, 140, 1209-1216.
28. Mattsby-Baltzer, I., Mielniczuk, Z., Larsson, L., Lindgren, K. and Goodwin, S. Lipid A in Helicobacter pylori. Infection and Immunity 1992, 60, 4383-4387.
29. Cunningham, M.D., Seachord, C., Ratcliffe, K., Bainbridge, B., Aruffo, A. and Darveau, R.P. Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14. Infection and Immunity 1996, 64, 3601-3608.
30. Joiner, K.A., Keith, P.W., McAdam, W.J. and Kasper, D.L. Lipopolysaccharides from Bacteroides fragilis are mitogenic for spleen cells from endotoxin responder and nonresponder mice. Infection and Immunity 1982, 36, 1139-1145.
31. Weintraub, A., Zähringer, U., Wollenweber, H.-W., Seydel, U. and Rietschel, E.T. Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. European Journal of Biochemistry 1989, 183, 425-431.
32. Johne, B., Olsen, I. and Bryn, K. Fatty acids and sugars in lipopolysaccharides from Bacteroides intermedius, Bacteroides gingivalis and Bacteroides loesheii. Oral Microbiology and Immunology 1988, 3, 22-27.
33. Flad, H.-D., Loppnow, H., Rietschel, E.T. and Ulmer, A.J. Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiology 1993, 187, 303-316.
34. Valkonen, K., Wadström, T. and Moran, A.P. Interaction of lipopolysaccharides of Helicobacter pylori with basement membrane protein laminin. Infection and Immunity 1994, 62, 3640-3648.
35. Kirikae, T., Inada, K., Hirata, M., Toshida, M., Galanos, C. and Lüderitz, O. Hemagglutination induced by lipopolysaccharides and lipid A. Microbiology and Immunology 1986, 30, 269-274.
36. Perez-Perez, G.I., Shepherd, V.L., Morrow, J.D. and Blaser, M.J. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infection and Immunity 1995, 63, 1183-1187.
37. Huang, J., O'toole, P.W., Doig, P. and Trust, T.J. Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infection and Immunity 1995, 63, 1732-1738.
38. Tamura, M., Tokuda, M., Nagaoka, S. and Takada, H. Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures. Infection and Immunity 1992, 60, 4932-4937.
39. Watanabe, A., Takeshita, A., Kitano, S. and Hanazawa, S. CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infection and Immunity 1996, 64, 4488-4494.
40. Hayashi, J., Masaka, T., Saito, I. and Ishikawa, I. Soluble CD14 mediates lipopolysaccharide-indiced intercellular adhesion molecule 1 expression in cultured human gingival fibroblasts. Infection and Immunity 1996, 64, 4946-4951.
41. Crowe, S.E., Alvarez, L., Dytoc, M., Hunt, R.H., Muller, M., Sherman, P., Patel, J., Jin, Y. and Ernst, P.B. Expression of interleukin 8 and CD54 by human gastric epithelial after Helicobacter pylori infection in vitro. Gastroenterology 1995, 108, 65-74.
42. Ogawa, T. and Uchida, H. Differential induction of IL-1β and IL-6 production by the nontoxic lipid A from Porphyromonas gingivalis in comparison with synthetic Escherichia coli lipid A in human peripheral blood mononuclear cells. FEMS Immunology and Medical Microbiology 1996, 14, 1-13.
43. Baggiolini, M. and Clark-Lewis, I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Letters 1992, 307, 97-101.
44. Nielsen, H., Birkholz, S., Andersen, L.P. and Moran, A.P. Neutrophil activation by H. pylori lipopolysaccharides. Journal of Infectious Diseases 1994, 170, 135-139.
45. Tarkkanen, J., Kosunen, T.U. and Saksela, E. Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infection and Immunity 1993, 61, 3012-3016.
46. Darveau, R.P., Cunningham, M.D., Bailey, T., Seachord, C., Ratcliffe, K., Bainbridge, B., Dietsch, M., Page, R.C. and Aruffo, A. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infection and Immunity 1995, 63, 1311-1317.